Express Scripts (NASDAQ:ESRX) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a report released on Wednesday.
Several other brokerages have also commented on ESRX. SunTrust Banks reissued a “buy” rating and set a $95.00 price target on shares of Express Scripts in a research note on Friday, January 12th. Zacks Investment Research lowered Express Scripts from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Robert W. Baird raised Express Scripts from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $72.00 to $81.00 in a research note on Friday, December 15th. William Blair lowered Express Scripts from an “outperform” rating to a “market perform” rating in a research note on Thursday, March 8th. Finally, Raymond James Financial reissued a “sell” rating on shares of Express Scripts in a research note on Friday, December 15th. Three investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $81.97.
Express Scripts (NASDAQ:ESRX) opened at $76.33 on Wednesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.55 and a current ratio of 0.67. Express Scripts has a 52-week low of $55.80 and a 52-week high of $85.07. The stock has a market capitalization of $43,046.87, a P/E ratio of 9.75, a price-to-earnings-growth ratio of 0.94 and a beta of 0.94.
Express Scripts (NASDAQ:ESRX) last released its earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.09 by $0.07. The company had revenue of $25.38 billion for the quarter, compared to analysts’ expectations of $25.07 billion. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.88 EPS. sell-side analysts forecast that Express Scripts will post 9.35 earnings per share for the current fiscal year.
Express Scripts announced that its board has initiated a share repurchase plan on Monday, December 18th that authorizes the company to repurchase 45,000,000 outstanding shares. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s board believes its shares are undervalued.
In other Express Scripts news, VP Glen D. Stettin sold 3,449 shares of the stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the transaction, the vice president now owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Everett Neville sold 4,895 shares of the stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total value of $368,397.70. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,792 shares of company stock worth $909,815. 0.68% of the stock is owned by corporate insiders.
Several institutional investors have recently modified their holdings of the business. Bank of New York Mellon Corp lifted its stake in shares of Express Scripts by 8.7% during the 4th quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock worth $618,609,000 after purchasing an additional 666,754 shares during the period. Nordea Investment Management AB lifted its stake in shares of Express Scripts by 2.6% during the 3rd quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock worth $462,551,000 after purchasing an additional 188,528 shares during the period. Geode Capital Management LLC lifted its stake in shares of Express Scripts by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock worth $492,297,000 after purchasing an additional 32,548 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Express Scripts by 1.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 6,545,076 shares of the company’s stock worth $414,419,000 after purchasing an additional 86,800 shares during the period. Finally, Ameriprise Financial Inc. lifted its stake in shares of Express Scripts by 23.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after purchasing an additional 996,816 shares during the period. 89.08% of the stock is currently owned by institutional investors.
WARNING: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/03/16/express-scripts-esrx-rating-lowered-to-hold-at-bidaskclub.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.